For citations:
Gafanov R.A., Dzidzaria A.G., Kravtsov I.B., Fastovets S.V. Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma? Cancer Urology. 2020;16(3):29-37. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-3-29-37
Email this article 